Form 8-K - Current report:
SEC Accession No. 0000950103-22-011120
Filing Date
2022-06-23
Accepted
2022-06-23 16:45:25
Documents
15
Period of Report
2022-06-21
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K dp175752_8k.htm   iXBRL 8-K 36581
2 EXHIBIT 10.1 dp175752_ex1001.htm EX-10.1 152650
3 EXHIBIT 99.1 dp175752_ex9901.htm EX-99.1 14299
4 GRAPHIC image_001.jpg GRAPHIC 3615
  Complete submission text file 0000950103-22-011120.txt   423990

Data Files

Seq Description Document Type Size
5 XBRL SCHEMA FILE blco-20220621.xsd EX-101.SCH 3027
6 XBRL LABEL FILE blco-20220621_lab.xml EX-101.LAB 34476
7 XBRL PRESENTATION FILE blco-20220621_pre.xml EX-101.PRE 22591
9 EXTRACTED XBRL INSTANCE DOCUMENT dp175752_8k_htm.xml XML 3582
Mailing Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4
Business Address 520 APPLEWOOD CRESCENT VAUGHAN A6 L4K 4B4 908-541-5456
Bausch & Lomb Corp (Filer) CIK: 0001860742 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-41380 | Film No.: 221036012
SIC: 3851 Ophthalmic Goods